These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 36744555)

  • 1. Eliminating Potential Effects of Other Infections During Selection of Nonhuman Primates for COVID-19 Research.
    Andrade MCR; Lemos BRP; Silva LM; Pecotte JK
    Comp Med; 2023 Feb; 73(1):45-57. PubMed ID: 36744555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 in Captive Nonhuman Primates, Spain, 2020-2023.
    Cano-Terriza D; Beato-Benítez A; Fernández-Bastit L; Segalés J; Vergara-Alert J; Martínez-Nevado E; Carretero A; Crailsheim D; Soriano P; Planas J; Torro M; García-Bocanegra I
    Emerg Infect Dis; 2024 Jun; 30(6):1253-1257. PubMed ID: 38782139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal Models of COVID-19: Nonhuman Primates.
    Singh DK; Cole J; Escobedo RA; Alfson KJ; Singh B; Lee TH; Alvarez X; Ganatra SR; Carrion R; Kaushal D
    Methods Mol Biol; 2022; 2452():227-258. PubMed ID: 35554911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No Evidence of SARS-CoV-2 Infection in Neotropical Primates Sampled During COVID-19 Pandemic in Minas Gerais and Rio Grande do Sul, Brazil.
    de Abreu FVS; Macedo MV; da Silva AJJ; de Oliveira CH; de Ottone VO; de Almeida MAB; Dos Santos E; da Cardoso JC; Campos AS; da Silva CMD; da Silva AG; de Andrade MS; Bernis VMO; Bernis Filho WO; de Trindade GS; Albuquerque GR; da Sevá AP; Ribeiro BM; Teixeira DS; Campos FS; Franco AC; Roehe PM; de Oliveira DB
    Ecohealth; 2021 Dec; 18(4):414-420. PubMed ID: 34843021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of an African green monkey model for COVID-19.
    Woolsey C; Borisevich V; Prasad AN; Agans KN; Deer DJ; Dobias NS; Heymann JC; Foster SL; Levine CB; Medina L; Melody K; Geisbert JB; Fenton KA; Geisbert TW; Cross RW
    bioRxiv; 2020 May; ():. PubMed ID: 32511377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the Respiratory Viral Panel PCR Test Results Before and After COVID-19 Pandemic].
    Alp A; Taşçı O; Ergin A; Köseoğlu Eser Ö
    Mikrobiyol Bul; 2022 Oct; 56(4):667-681. PubMed ID: 36458713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Dose-Response Relationships for Two Isolates of SARS-CoV-2 in a Nonhuman Primate Model of Inhalational COVID-19.
    Dabisch PA; Sanjak JS; Boydston JA; Yeager J; Herzog A; Biryukov J; Beck K; Do D; Seman BG; Green B; Bohannon JK; Holland B; Miller D; Ammons T; Freeburger D; Miller S; Jenkins T; Rippeon S; Miller J; Clarke D; Manan E; Patty A; Rhodes K; Sweeney T; Winpigler M; Altamura LA; Zimmerman H; Hail AS; Wahl V; Hevey M
    J Aerosol Med Pulm Drug Deliv; 2022 Dec; 35(6):296-306. PubMed ID: 36318785
    [No Abstract]   [Full Text] [Related]  

  • 10. Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.
    Crisan-Dabija R; Grigorescu C; Pavel CA; Artene B; Popa IV; Cernomaz A; Burlacu A
    Can Respir J; 2020; 2020():1401053. PubMed ID: 32934758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coinfection With SARS-CoV-2 and Influenza A(H1N1) in a Patient Seen at an Influenza-like Illness Surveillance Site in Egypt: Case Report.
    Fahim M; Ghonim HAES; Roshdy WH; Naguib A; Elguindy N; AbdelFatah M; Hassany M; Mohsen A; Afifi S; Eid A
    JMIR Public Health Surveill; 2021 Apr; 7(4):e27433. PubMed ID: 33784634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of Nonhuman Primate Models of SARS-CoV-2 Infection.
    Trichel AM
    Comp Med; 2021 Oct; 71(5):411-432. PubMed ID: 34548126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets.
    Huang Y; Skarlupka AL; Jang H; Blas-Machado U; Holladay N; Hogan RJ; Ross TM
    J Virol; 2022 Mar; 96(5):e0179121. PubMed ID: 34936487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B.1.351 SARS-CoV-2 Variant Exhibits Higher Virulence but Less Viral Shedding than That of the Ancestral Strain in Young Nonhuman Primates.
    Bai Y; He Q; Yang J; Lu S; Mao Q; Gao F; Bian L; Zhang J; An C; Liu J; Wu X; Yu W; Wang Z; Peng X; Wang J; Liang Z; Xu M
    Microbiol Spectr; 2022 Oct; 10(5):e0226322. PubMed ID: 36069561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonhuman primate models for evaluation of SARS-CoV-2 vaccines.
    Neil JA; Griffith M; Godfrey DI; Purcell DFJ; Deliyannis G; Jackson D; Rockman S; Subbarao K; Nolan T
    Expert Rev Vaccines; 2022 Aug; 21(8):1055-1070. PubMed ID: 35652289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4
    Kim EH; Nguyen TQ; Casel MAB; Rollon R; Kim SM; Kim YI; Yu KM; Jang SG; Yang J; Poo H; Jung JU; Choi YK
    J Virol; 2022 Mar; 96(6):e0187321. PubMed ID: 35107382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel machine-learning analysis of SARS-CoV-2 infection in a subclinical nonhuman primate model using radiomics and blood biomarkers.
    Chu WT; Castro MA; Reza S; Cooper TK; Bartlinski S; Bradley D; Anthony SM; Worwa G; Finch CL; Kuhn JH; Crozier I; Solomon J
    Sci Rep; 2023 Nov; 13(1):19607. PubMed ID: 37950044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
    Oishi K; Horiuchi S; Minkoff JM; tenOever BR
    J Virol; 2022 Aug; 96(15):e0076522. PubMed ID: 35862681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014.
    Davis AS; Taubenberger JK; Bray M
    Antiviral Res; 2015 May; 117():75-98. PubMed ID: 25746173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA and industry collaboration: Identifying opportunities to further reduce reliance on nonhuman primates for nonclinical safety evaluations.
    Ackley D; Birkebak J; Blumel J; Bourcier T; de Zafra C; Goodwin A; Halpern W; Herzyk D; Kronenberg S; Mauthe R; Shenton J; Shuey D; Wange RL
    Regul Toxicol Pharmacol; 2023 Feb; 138():105327. PubMed ID: 36586472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.